600557 Jiangsu Kanion Pharmaceutical
- 14.48
- +0.31+2.19%
Jiangsu Kanion Pharmaceutical News
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions
Kangyuan Pharmaceutical: Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the main operating data for the first three quarters of 2024
Kangyuan Pharmaceutical: Report for the Third Quarter of 2024 by Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the main operating data for the first three quarters of 2024
Jiangsu Kangyuan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Kangyuan Pharmaceutical: Announcement of the progress of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on completing the registration of industrial and commercial changes and issuing a business license
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the repurchase ratio of the company\'s shares reached 2% through centralized bidding transactions and the progress of the repurchase
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on receiving the KYS202004A injection clinical trial approval notice
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions
Announcement of Jiangsu Kanion Pharmaceutical Co., Ltd. Obtaining the Registration Certificate for Wenyang Detoxification Granules
Rules for the Board of Directors Meeting of Jiangsu Kanion Pharmaceutical Co., Ltd. (Revised on August 12, 2024)
Shareholders' meeting rules of Jiangsu Kanion Pharmaceutical Co., Ltd. (revised on August 12, 2024)
Jiangsu Kanion Pharmaceutical Co., Ltd. Independent Director System (Revised on August 12, 2024)
Jiangsu Kanion Pharmaceutical Co., Ltd. Company Charter (revised on August 12, 2024)
Legal opinion of Jiangsu Century Tongren Law Firm on the first interim shareholders' meeting of Jiangsu Kanion Pharmaceutical Co., Ltd. in 2024.
Announcement of the resolutions of the first extraordinary shareholders' meeting of Jiangsu Kanion Pharmaceutical Co., Ltd. in 2024.
Reply announcement regarding regulatory letter from Shanghai Stock Exchange on related party transactions of Jiangsu Kanion Pharmaceutical Co., Ltd.
Announcement on the Progress of Jiangsu Kanion Pharmaceutical Co., Ltd.'s Repurchase of Company Shares through Centralized Bidding Trading
Analysis
Price Target
No Data
No Data